Image pharmaphorum Editor Patients 2021 in review: Building the framework of a patient-centric ... Patient centricity and patient engagement have been hot topics in pharma for some time – but buzz words do not always translate into concrete action. R&D Drug development and working with specialised Rare Disease n... There are currently an estimated 300 million people living with one or more Rare Diseases across the world. News Frontiers Health 2021 Spotlight Digital Frontiers Health Digital Innovators: Aptar’s Sai Shankar Continuing his Frontiers Health Digital Innovator's series, pharmaphorum’s founder, Dr Paul Tunnah, speaks with president of Digital Health Sai Shankar. At Frontiers Health Load more results
Patients 2021 in review: Building the framework of a patient-centric ... Patient centricity and patient engagement have been hot topics in pharma for some time – but buzz words do not always translate into concrete action.
R&D Drug development and working with specialised Rare Disease n... There are currently an estimated 300 million people living with one or more Rare Diseases across the world.
Digital Frontiers Health Digital Innovators: Aptar’s Sai Shankar Continuing his Frontiers Health Digital Innovator's series, pharmaphorum’s founder, Dr Paul Tunnah, speaks with president of Digital Health Sai Shankar. At Frontiers Health
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
